🇺🇸 FDA
Patent

US 10463663

Pyridazinone compounds and their use as DAAO inhibitors

granted A61KA61K31/50A61K31/501

Quick answer

US patent 10463663 (Pyridazinone compounds and their use as DAAO inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/50, A61K31/501, A61K45/06, A61P